WHO approves Bharat Biotech’s Covaxin

Prime News, International, National, Health, Disease, Vaccine, New Delhi, November 4:- Covaxin, India’s indigenously developed coronavirus vaccine by Bharat Biotech, has been recommended for emergency use by the World Health Organisation (WHO). The Technical Advisory Group of WHO on Wednesday (November 3) recommended Covaxin for emergency use status.

The Technical Advisory Group (TAG), an independent advisory committee of the World Health Organisation (WHO), recommended Emergency Use Listing (EUL) status for Bharat Biotech COVID-19 vaccine Covaxin, sources in the know of the development said.

“Technical Advisory Group, convened by WHO and made up of regulatory experts from around the world, has determined that Covaxin vaccine meets WHO standards for protection against COVID, that benefit of the vaccine far outweighs risks and the vaccine can be used across the world,” the world health body said.

“Covaxin vaccine was also reviewed by WHO’s Strategic Advisory Group of Experts on Immunisation (SAGE), and recommended the use of this vaccine in two doses, with a dose interval of four weeks, in all age groups 18 and above,” it said.

“Glad to see one more vaccine, Covaxin, being granted WHO emergency use listing. The more products we have to fight Covid-19, the better,” said WHO DG Dr Tedros Adhanom Ghebreyesus.

Following approval from WHO, Union Health Minister Mansukh Mandaviya thanked the world health body for Emergency Use Listing (EUL) to Made-in-India Covaxin.

Taking to Twitter, Mandaviya wrote, “This is a sign of a capable leadership. This is the story of Modi Ji’s resolve.” (MR, Inputs: Agencies)

Leave a Reply



Related Articles